Flavonoid compositions and methods of use
Flavonoid compositions containing the flavonoid quercetin and/or derivatives of quercetin are disclosed. The flavonoid compositions are formulated to improve the bioavailability of quercetin. Also provided herein are methods for improving athletic performance, improving cardiovascular health, and aiding in immune response and methods of improving athletic performance, improving bone health, preventing fatigue, reducing recovery time after exercise, countering oxidative stress, and/or boosting energy.
1. A method for preventing, improving, or ameliorating a disorder of a subject, comprising administering to the subject an oral ingestible medicament comprising:
a flavonoid comprising quercetin present in an amount of about 7.9% to about 16% w/w;
an antioxidant;
an anthocyanidin;
a stimulant;
a lipid;
ascorbic acid;
an omega 3 fatty acid; and
ascorbyl palmitate;
wherein the oral ingestible medicament is a capsule, a chewable tablet, a gummy, or a powder, and
wherein the disorder is an acute respiratory illness, an allergic reaction, arthritis, asthma, a cancer, a cardiovascular disease, diabetes, a heart disease, hypertension, a neurodegenerative disease, oxidative stress, a prostate disease, systemic inflammation, or weight gain.
2. The method of claim 1 , wherein a daily dose of medicament comprises about 10 to about 500 mg of flavonoid.
3. The method of claim 1 , wherein the oral ingestible medicament increases total urinary phenolic concentration, dietary flavonoid intake, dietary anthocyanin, dietary antioxidant, or dietary quercetin.
4. The method of claim 1 , wherein the oral ingestible medicament reduces the risk of neurodegenerative diseases, weight gain, systemic inflammation, oxidative stress, diabetes, cardiovascular disease, hypertension, or acute respiratory illness.
5. The method of claim 1 , wherein the oral ingestible medicament improves colon health or colon microbiome.
6. The method of claim 1 , wherein the oral ingestible medicament reduces blood pressure or LDL cholesterol in the subject.
7. The method of claim 1 , wherein the oral ingestible medicament increases flavonoid, flavan-3-ol, flavonol, or anthocyanidin availability in the subject.
8. The method of claim 1 , wherein the oral ingestible medicament increases mitochondrial biogenesis in a subject.
9. The method of claim 1 , wherein the flavonoid is derived from a blueberry or bilberry fruit extract.
10. The method of claim 1 , wherein the antioxidant is a green tea extract having EGCG.
11. The method of claim 10 , wherein the oral ingestible medicaments increases dietary EGCG in the subject.
12. The method of claim 1 , wherein the composition further comprises a bioavailability enhancing agent.
13. The method of claim 12 , wherein the bioavailability enhancing agent comprises a solubilizing agent, a reducing compound, a stabilizing compound, a lubricating compound, an enteric coating, or a permeability enhancing compound.
14. The method of claim 1 , wherein the composition is administered to the subject two to four times each day.
15. The method of claim 1 , wherein the stimulant is caffeine.
16. The method of claim 1 , wherein the composition further comprises one or more sugar, natural or artificial flavors, cellulose gum, sucralose, bamboo whole plant extract, guar gum, xanthan gum, citric acid, malic acid, or L-tartaric acid.
17. The method of claim 1 , wherein the omega 3 fatty acid comprises docosahexaenoic acid and eicosapentaenoic acid.
18. The method of claim 1 , wherein the composition further comprises one or more proteins.
19. The method of claim 18 , wherein the one or more proteins include one or more of dairy protein, soy protein, or whey protein.